Paternal exposure to antirheumatic drugs—What physicians should know: Review of the literature
Authors:
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 48 (2) , 343-355
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnnals of the Rheumatic Diseases, 2012
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ RegistryAmerican Journal of Gastroenterology, 2012
- The influence of immunosuppressants on the fertility of males who undergo renal transplantation and on the immune function of their offspringTransplant Immunology, 2009
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeAnnals of the Rheumatic Diseases, 2009
- Chronic Cyclophosphamide Exposure Alters the Profile of Rat Sperm Nuclear Matrix Proteins1Biology of Reproduction, 2007
- Fertility and pregnancy in the patient with inflammatory bowel diseaseGut, 2006
- Reversibility of the effects of chronic paternal exposure to cyclophosphamide on pregnancy outcome in ratsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Incidence of sulphasalazine-induced male infertility.Gut, 1981
- Colchicine inhibits mitogenesis in C1300 neuroblastoma cells that have been arrested in G0Nature, 1976
- CYCLOPHOSPHAMIDE THERAPY AND STERILITYThe Lancet, 1972